GlobeNewswire

Surrozen to Present at Upcoming Healthcare Investor Conference
05/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
05/02/2026
CONSHOHOCKEN, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update
05/02/2026
NOVATO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra- [...]
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
05/02/2026
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the following two upcoming investor conferences: TD Cowen 46 th [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
05/02/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
05/02/2026
HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Coeptis Receives Shareholder Approval Towards Z Squared Merger
05/02/2026
Shareholder Approval Clears a Key Condition to Close WEXFORD, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/2026
WESTLAKE VILLAGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update
05/02/2026
February 5, 2026 Announcement no. 1 BioPorto provides Preliminary Unaudited 2025 Financial Figures, Financial Guidance for 2026 and a Business Update COPENHAGEN, DENMARK, February 5, 2026, (GLOBE NEWSWIRE) – BioPorto A/ [...]
Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™
05/02/2026
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrum Launch readiness established in [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
05/02/2026
Bagsværd, Denmark, 5 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Organic & Natural Health Association Honors SENPA’s Debra Short with Champion Award at Conference Shaping Policy, and the Future of Retail
05/02/2026
FT. LAUDERDALE, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association ’s 11th annual conference, “The United States of Health: Building Bridges to Opportunity,” concluded Jan. 22 with a [...]
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
05/02/2026
The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines achieving U.S. FDA approval before September 2029 The Pediatric Priority [...]
Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026
– Live video webcast on Wednesday, February 11 th at 1:20 PM EST HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will [...]
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05/02/2026
– Live video webcast on Wednesday, February 11 th at 1:00 PM EST LA JOLLA, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative [...]
NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant
05/02/2026
ATHENS, Ga., Feb. 05, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals Inc.’s (OTC: NDTP) (“Company”) wholly owned subsidiary, Good Salt Life, announces that its flagship product, Clean Republic Multipurpose Disinfectant (“ [...]
ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer
05/02/2026
– Seasoned clinical development leader brings more than 25 years of deep expertise in clinical development and operations across biotech and healthcare industry – SAN DIEGO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- [...]
Lighthouse Autism Center Announces Opening of New Cedar Falls, IA Location
05/02/2026
Premier ABA Provider Expands Services with 50th Location Nationwide CEDAR FALLS, Iowa, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a leading provider of center-based Applied Behavior Analysis (ABA) [...]
Guerbet : Chiffre d’affaires 2025.
05/02/2026
Chiffre d’affaires 2025 Chiffre d’affaires annuel : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , largement dû à la baisse de l’activité en France Au quatrième trimestre, une baisse de 5,6% à TCC [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum